Physician profile
Julia Gajewski
NPI 1841719572
$16,462.47
in general payments reported to CMS, 2019-2025
14 companies · $3,822 in 2025
The $3,822 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,334 · 2022: $4,662 · 2023: $2,796 · 2024: $1,849 · 2025: $3,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,206 · Travel and Lodging: $2,669 · Education: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,206.16 |
| Travel and Lodging | $2,668.70 |
| Education | $591.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $8,044.24 | 2021-2024 | Senza |
| Abbott Laboratories | $4,959.67 | 2021-2025 | Proclaim, Eterna, Thoratec Heartmate 3 Lvas Implant Kit |
| Abbvie INC. | $903.63 | 2021-2025 | |
| Nalu Medical, INC. | $735.57 | 2024-2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $691.99 | 2025 | Senza, Omnia, Vyrsa V1 |
| Medtronic, INC. | $359.94 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Si-Bone, INC. | $262.99 | 2021-2025 | |
| Boston Scientific Corporation | $186.64 | 2022-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Saluda Medical Americas, INC. | $163.44 | 2024-2025 | Evoke |
| Averitas Pharma INC. | $69.38 | 2024-2025 | Qutenza |
| Pacira Therapeutics, INC. | $24.32 | 2021 | |
| Spr Therapeutics, INC | $21.11 | 2023 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $20.77 | 2025 | |
| Allergan, INC. | $18.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Gajewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.